Procter & Gamble (PG)
(Delayed Data from NYSE)
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 5:24 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 5:24 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
What Awaits for Pilgrim's Pride's (PPC) Q2 Earnings Release?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance will reflect gains from robust market momentum and improved efficiency. However, an elevated cost environment is a hurdle.
Service Corporation (SCI) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2024 performance will likely reflect gains from strength in the Cemetery segment. However, a rising interest rate environment poses a threat.
Can Clorox's (CLX) Pricing & Cost-Saving Plan Aid Q4 Earnings?
by Zacks Equity Research
Clorox's (CLX) Q4 results are expected to reflect gains from pricing strategies and cost-saving initiatives, as well as progress on the IGNITE strategy, amid high SG&A expenses.
Market Awaits JOLTS Numbers Due Tuesday
by Zacks Equity Research
Market Awaits JOLTS Numbers Due Tuesday.
Big Numbers Ahead: Q2 Earnings, Fed Meeting, Jobs Week
by Mark Vickery
Jobs Week, Fed Week and the busiest week of Q2 earnings so far await us.
Hershey's (HSY) Q2 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Hershey's (HSY) Q2 results are likely to reflect gains from brand strength, but high commodity costs, increased selling, marketing and administrative expenses and currency volatility are concerns.
Is Procter & Gamble (PG) a Smart Investment Pre-Q4 Earnings?
by Rajani Lohia
While P&G's (PG) strong financial performance and strategic initiatives provide a solid foundation for growth in Q4, the external risks justify a neutral stance on its investment potential.
Colgate-Palmolive (CL) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 4.60% and 0.93%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Clorox (CLX) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Clorox (CLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Consumer Staples Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
Gear Up for P&G (PG) Q4 Earnings: Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of P&G (PG) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Should You Invest in the Vanguard Consumer Staples ETF (VDC)?
by Zacks Equity Research
Sector ETF report for VDC
Procter & Gamble (PG) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $168, marking a +0.83% move from the previous day.
Sysco's (SYY) Q4 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Sysco's (SYY) Q4 results are likely to reflect gains from the company's efforts to enhance volumes and improve efficiency through supply-chain productivity and cost-containment efforts.
Mondelez (MDLZ) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Mondelez's (MDLZ) Q2 results are likely to reflect the impacts of a tough operating landscape and input cost inflation, while pricing is likely to have aided the performance.
Will LAC Issues & Inflation Hurt Diageo's (DEO) FY24 Earnings?
by Zacks Equity Research
Diageo's (DEO) FY24 results are likely to reflect negative consumer sentiment and increased inventory levels in LAC, pressured further by escalating input costs.
Will P&G (PG) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
P&G (PG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Procter & Gamble (PG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble (PG) Rises But Trails Market: What Investors Should Know
by Zacks Equity Research
Procter & Gamble (PG) reachead $168.25 at the closing of the latest trading day, reflecting a +0.17% change compared to its last close.
Procter & Gamble (PG) Hits 52-Week High: Buy, Hold or Sell?
by Rajani Lohia
After Procter & Gamble (PG) hits a 52-week high, we assess whether the current level warrants an opportunity to accumulate shares, hold positions or book profits.
Procter & Gamble (PG) Rises Higher Than Market: Key Facts
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $166.95, marking a +1.44% move from the previous day.
Should You Invest in the Fidelity MSCI Consumer Staples Index ETF (FSTA)?
by Zacks Equity Research
Sector ETF report for FSTA
Procter & Gamble (PG) Ascends But Remains Behind Market: Some Facts to Note
by Zacks Equity Research
Procter & Gamble (PG) concluded the recent trading session at $166.80, signifying a +0.69% move from its prior day's close.